Detalhe da pesquisa
1.
C910 chemical compound inhibits the traffiking of several bacterial AB toxins with cross-protection against influenza virus.
iScience
; 25(7): 104537, 2022 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35769882
2.
Adjuvant Effect of Orally Applied Preparations Containing Non-Digestible Polysaccharides on Influenza Vaccination in Healthy Seniors: A Double-Blind, Randomised, Controlled Pilot Trial.
Nutrients
; 13(8)2021 Aug 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34444843
3.
Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol.
Pathogens
; 10(7)2021 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358061
4.
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques.
Nat Commun
; 12(1): 5215, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34471122
5.
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
EBioMedicine
; 70: 103495, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34304047
6.
Factors associated with non-persistence to oral and inhaled antiviral therapies for seasonal influenza: a secondary analysis of a double-blind, multicentre, randomised clinical trial.
BMJ Open
; 7(7): e014546, 2017 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28698321